{"id":1470550,"title":"DSEN Abstract: Safety, Effectiveness and Cost-effectiveness of Direct Oral Anti-coagulants in Patients with Atrial Fibrillation - CIHR","sourceCode":"cihr","sourceName":"Canadian Institutes of Health Research","language":"en","captureDate":"2026-04-07","captureTimestamp":"2026-04-07T17:44:26.016000+00:00","jobId":8,"originalUrl":"https://cihr-irsc.gc.ca/e/51391.html?wbdisable=true","snippet":"DSEN Abstract Safety, Effectiveness and Cost-effectiveness of Direct Oral Anti-coagulants in Patients with Atrial Fibrillation This research was funded by the Drug Safety and Effectiveness Network (DSEN) and conducted by the following investigators: George Wells, Doug Coyle,…","rawSnapshotUrl":"/api/snapshots/raw/1470550","browseUrl":"https://replay.healtharchive.ca/job-8/20260407174426/https://cihr-irsc.gc.ca/e/51391.html?wbdisable=true#ha_snapshot=1470550","mimeType":"text/html","statusCode":200,"captureBackend":"browsertrix","captureFidelity":"high"}